Tissue Engineering And Nanotheranostics

“9.61x6.69” b2815 Tissue Engineering and Nanotheranostics

Engineering Approaches for Creating Skeletal Muscle 23

skeletal muscle development, maintenance, and therapy. Mol. Ther.

15 (5), 867–877 (2007).

27. Doer flinger RM. Old and new ethics in the stem cell debate. J. Law
    Med. Ethics. 38 (2), 212–+ (2010).


28. Calder on D, Planat-Benard V, Bellamy V, Vanneaux V, Kuhn C, Peyrard S,
    Larghero J, Desnos M, Casteilla L, Pucat M, Menasch P, Chatenoud L.
    Immune response to human embryonic stem cell-derived cardiac progeni-
    tors and adipose-derived stromal cells. J. Cell. Mol. Med. 16 (7), 1544–1552
    (2012).


29. T akahashi K, Yamanaka S. Induction of pluripotent stem cells from
    mouse embryonic and adult fibroblast cultures by defined factors. Cell
    126 (4), 663–676 (2006).


30. Heslop JA, Hammond TG, Santeramo I, Tort Piella A, Hopp I, Zhou
    J, Baty R, Graziano EI, Proto Marco B, Caron A, Skld P, Andrews PW,
    Baxter MA, Hay DC, Hamdam J, Sharpe ME, Patel S, Jones DR,
    Reinhardt J, Danen EHJ, Ben-David U, Stacey G, Bjrquist P, Piner J,
    Mills J, Rowe C, Pellegrini G, Sethu S, Antoine DJ, Cross MJ, Murray
    P, Williams DP, Kitteringham NR, Goldring CEP, Park BK. Concise
    review: Workshop review: Understanding and assessing the risks of stem
    cell-based therapies. Stem Cells Transl. Med. 4 (4), 389–400 (2015).


31. Medvedev SP, Shevchenko AI, Zakian SM. Induced pluripotent stem
    cells: Problems and advantages when applying them in regenerative
    medicine. Acta Naturae 2 (2), 18–28 (2010).


32. Chamberlain G, Fox J, Ashton B, Middleton J. Concise review:
    Mesenchymal stem cells: Their phenotype, differentiation capacity,
    immunological features, and potential for homing. Stem Cells 25 (11),
    2739–2749 (2007).


33. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC,
    Krause DS, Deans RJ, Keating A, Prockop DJ, Horwitz EM. Minimal
    criteria for defining multipotent mesenchymal stromal cells. the interna-
    tional society for cellular therapy position statement. Cytotherapy 8 (4),
    315–317 (2006).


34. Ster n-Straeter J, Bonaterra GA, Juritz S, Birk R, UR. Goessler,
    Bieback K, Bugert P, Schultz J, Hormann K, Kinscherf R, Faber A.
    Evaluation of the effects of different culture media on the myogenic
    differentiation potential of adipose tissue- or bone marrow-derived
    human mesenchymal stem cells. Int. J. Mol. Med. 33 (1), 160–170
    (2014).

b2815_Ch-01.indd 23 11-10-2017 06:32:17 PM